4DMedical Limited
FDMDF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $5,853 | $3,050 | $719 | $1,054 |
| % Growth | 91.9% | 324.4% | -31.8% | – |
| Cost of Goods Sold | $464 | $237 | $24,996 | $774 |
| Gross Profit | $5,389 | $2,813 | -$24,278 | $281 |
| % Margin | 92.1% | 92.2% | -3,378.6% | 26.6% |
| R&D Expenses | $2,508 | $694 | $7,599 | $3,267 |
| G&A Expenses | $0 | $28,752 | $23,153 | $20,528 |
| SG&A Expenses | $32,102 | $30,167 | $25,112 | $19,215 |
| Sales & Mktg Exp. | $0 | $1,415 | $1,958 | $1,373 |
| Other Operating Expenses | $0 | $18,561 | -$12,419 | $0 |
| Operating Expenses | $34,609 | $49,423 | $20,292 | $22,482 |
| Operating Income | -$29,220 | -$46,610 | -$30,653 | -$22,201 |
| % Margin | -499.2% | -1,528.4% | -4,265.8% | -2,105.8% |
| Other Income/Exp. Net | -$937 | $10,679 | -$483 | -$2,349 |
| Pre-Tax Income | -$30,157 | -$35,930 | -$31,137 | -$24,550 |
| Tax Expense | $87 | $48 | $323 | $43 |
| Net Income | -$30,070 | -$35,979 | -$31,460 | -$24,593 |
| % Margin | -513.7% | -1,179.8% | -4,378% | -2,332.6% |
| EPS | -0.071 | -0.11 | -0.1 | -0.084 |
| % Growth | 35.5% | -10% | -19.8% | – |
| EPS Diluted | -0.14 | -0.097 | -0.1 | -0.084 |
| Weighted Avg Shares Out | 214,785 | 327,079 | 300,014 | 294,508 |
| Weighted Avg Shares Out Dil | 424,282 | 370,473 | 300,014 | 294,508 |
| Supplemental Information | – | – | – | – |
| Interest Income | $80 | $1,237 | $608 | $93 |
| Interest Expense | $0 | $264 | $294 | $180 |
| Depreciation & Amortization | $1,452 | $4,065 | $737 | $1,496 |
| EBITDA | -$46,047 | -$31,857 | -$43,832 | -$35,255 |
| % Margin | -786.7% | -1,044.6% | -6,099.9% | -3,343.9% |